Understanding Trial Phases, Study Design, and Oversight From a Regulatory Perspective
- 0:00 Why Regulators Read Trials
- 8:00 Phase Purpose And Evidence
- 18:00 Design Choices That Matter
Practical shifts you can apply this week
-
Identify Trial Phase Expectations
Identify the regulatory purpose and evidentiary expectations of each major trial phase.
-
Compare Design Tradeoffs Clearly
Compare common study design choices by the risks they create for bias, safety, and interpretability.
-
Evaluate Oversight Responsibilities
Evaluate oversight responsibilities across sponsors, investigators, IRBs/IECs, DSMBs, and regulators.
-
Diagnose Common Regulatory Issues
Diagnose protocol and conduct issues that commonly trigger findings, delays, or requests for clarification.
-
Design A Review Lens
Design a simple review lens for aligning development decisions with inspection and approval readiness.
What we'll cover
-
0:00
Why Regulators Read Trials
Hook and framing. See how phase, design, and oversight connect to approval and inspection outcomes.
-
8:00
Phase Purpose And Evidence
Phase 0 through IV, what each phase is meant to answer, and where teams ask the wrong questions.
-
18:00
Design Choices That Matter
Endpoints, comparators, blinding, randomization, estimands, and population choices regulators notice fast.
-
30:00
Adaptive And Platform Designs
Guardrails for adaptive formats, interim analyses, alpha control, and governance before data get persuasive.
-
38:00
Safety Oversight In Practice
AE to SUSAR pathways, DSMBs, stopping rules, urgent safety measures, and escalation logic that holds up.
-
47:00
Who Owns What
Sponsors, investigators, IRBs/IECs, CROs, and regulators each have distinct duties. Gaps become findings.
-
54:00
Failure Modes And Recap
Common design and conduct problems, a simple readiness lens, and one practical review step for this week.
-
58:00
Q&A And Next Step
Bring a live study question or use the closing framework to stress-test one protocol in your portfolio.
Questions people ask before registering
-
It is built for working professionals who touch clinical development, study operations, medical affairs, QA, regulatory, or oversight. If you review protocols or study risks, it will be useful.
-
No. The session starts with the logic regulators use, then builds into examples. People with experience should still find the review lens practical, not remedial.
-
Most webinar programs provide a replay to registered attendees, but availability depends on the host. If replay access matters, register and check the confirmation details.
-
Real examples are woven throughout, including Elevidys, I-SPY 2, RECOVERY, and a hypothetical Phase II oncology study. The point is to make regulatory logic feel usable on Monday morning.
-
A certificate or CE credit depends on the webinar host's setup. This page does not confirm either, so please check the registration or event details for specifics.
-
Pricing is set by the host and is not listed here. Open the registration page for the current attendance details.